TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.
Also called NCT07460960
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose other
- Phase
- Phase 2
- Enrolled
- 150 participants
- Sponsor
- Lomonosov Moscow State University Medical Research and Educational Center
- Registry
-
NCT07460960
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Russia
- Registry status
- Recruiting
Technical summary
Registry record NCT07460960. Randomized; no masking; primary purpose other. Start 2026-03-05 (actual); primary completion 2027-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men
- Condition
- Erectile Dysfunction Due to Arterial Disease
- Condition
- Atheroscleroses
- Condition
- Erectile Disfunction
- Condition
- Endothelial Dysfunction
- Condition
- Androgen Profile
- Condition
- Testosterone
- Intervention (Drug)
- Pitavastatin 1-4 mg daily
- Intervention (Drug)
- Rosuvastatin 20-40 mg daily
- Lead sponsor
- Lomonosov Moscow State University Medical Research and Educational Center
- Collaborator
- Nizhpharm
Record details
- Record id
cardio:ct-nct07460960- Content hash
c8265dfd47fa7d11bdec3d17f818133c05612dfc474af9abf42cb7c34b016ae6